Co-Authors
This is a "connection" page, showing publications co-authored by Roberto Gerli and Giacomo Cafaro.
Connection Strength
1.236
-
Correspondence on 'Anti-inflammatory therapy for COVID-19 infection: the case for colchicine'. Ann Rheum Dis. 2021 Jan 28.
Score: 0.232
-
Hypertension and SARS-CoV-2 infection: is inflammation the missing link? Cardiovasc Res. 2020 11 01; 116(13):e193-e194.
Score: 0.228
-
COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy. Immunol Res. 2020 08; 68(4):213-224.
Score: 0.224
-
The differential response to anti IL-6 treatment in COVID-19: the genetic counterpart. Clin Exp Rheumatol. 2020 May-Jun; 38(3):580.
Score: 0.220
-
The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19. J Autoimmun. 2020 07; 111:102468.
Score: 0.219
-
Intravenous Immunoglobulins at the Crossroad of Autoimmunity and Viral Infections. Microorganisms. 2021 Jan 07; 9(1).
Score: 0.058
-
Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases. Clin Exp Rheumatol. 2020 Jul-Aug; 38(4):754-759.
Score: 0.056